資訊|論壇|病例

搜索

首頁 醫(yī)學(xué)論壇 專業(yè)文章 醫(yī)學(xué)進展 簽約作者 病例中心 快問診所 愛醫(yī)培訓(xùn) 醫(yī)學(xué)考試 在線題庫 醫(yī)學(xué)會議

您所在的位置:首頁 > 肝病科診療指南 > EASL臨床實踐指南_肝硬化腹水、自發(fā)性腹膜炎

EASL臨床實踐指南_肝硬化腹水、自發(fā)性腹膜炎

2013-08-28 10:14 閱讀:1722 來源:愛愛醫(yī)資源網(wǎng) 責(zé)任編輯:愛愛醫(yī)資源
[導(dǎo)讀] Ascites is the most common complication of cirrhosis, and 60% of patients with compensated cirrhosis develop ascites within 10 years during the course of their disease [1]. Ascites only occurs when portal hypertension has developed [2] and

    《EASL臨床實踐指南_肝硬化腹水、自發(fā)性腹膜炎》內(nèi)容預(yù)覽

    Ascites is the most common complication of cirrhosis, and 60% of patients with compensated cirrhosis develop ascites within 10 years during the course of their disease [1]. Ascites only occurs when portal hypertension has developed [2] and is primarily related to an inability to excrete an adequate amount of sodium into urine, leading to a positive sodium balance. A large body of evidence suggests that renal sodium retention in patients with cirrhosis is secondary to arterial splanchnic vasodilation. This causes a decrease in effective arterial blood volume with activa-tion of arterial and cardiopulmonary volume receptors, and homeostatic activation of vasoconstrictor and sodium-retaining systems (i.e., the sympathetic nervous system and the renin–angiotensin–aldosterone system). Renal sodium retention leads to expansion of the extracellular fluid volume and formation of ascites and edema [3–5]. The development of ascites is associated with a poor prognosis and impaired quality of life in patients with cirrhosis [6,7]. Thus, patients with ascites should generally be considered for referral for liver transplantation. There is a clear rationale for the management of ascites in patients with cirrhosis, as successful treatment may improve outcome and symptoms.
A panel of experts was selected by the EASL Governing Board and met several times to discuss and write these guidelines during 2008–2009. These guidelines were written according to published studies retrieved from Pubmed. The evidence and recommendations made in these guidelines have been graded according to the GRADE system (Grading of Recommendations Assessment Development and Evaluation). The strength of evi-dence has been classified into three levels: A, high; B, moderate; and C, low-quality evidence, while that of the recommendation into two: strong and weak (Table 1). Where no clear evidence existed, the recommendations were based on the consensus advice of expert opinion(s) in the literature and that of the writing committee.

    點擊下載完整版:《EASL臨床實踐指南_肝硬化腹水、自發(fā)性腹膜炎》

    相關(guān)專題鏈接:自發(fā)性細菌性腹膜炎的臨床診斷及治療


分享到:
  版權(quán)聲明:

  本站所注明來源為"愛愛醫(yī)"的文章,版權(quán)歸作者與本站共同所有,非經(jīng)授權(quán)不得轉(zhuǎn)載。

  本站所有轉(zhuǎn)載文章系出于傳遞更多信息之目的,且明確注明來源和作者,不希望被轉(zhuǎn)載的媒體或個人可與我們

  聯(lián)系zlzs@120.net,我們將立即進行刪除處理

意見反饋 關(guān)于我們 隱私保護 版權(quán)聲明 友情鏈接 聯(lián)系我們

Copyright 2002-2024 Iiyi.Com All Rights Reserved